Vivos
VVOS
Vivos (VVOS) news
Recent news
Photovoltaic stocks rose in premarket trading, with JinkoSolar gaining 3.9%, Canadian Solar up 4.7% and Vivos Energy rising rising 4.5%.
AInvest Wire · Oct 5, 2026Vivos Therapeutics - Dismisses Baker Tilly US, LLP as independent auditor effective Sept 29, 2026 - SEC filing
AInvest Wire · Oct 1, 2026Vivos Therapeutics - Audit reports for FY2025 and FY2024 include substantial doubt about going concern - SEC filing
AInvest Wire · Oct 1, 2026Vivos Therapeutics - Primary savings from staff reductions, vendor changes, and contract savings
Vivos Therapeutics (NASDAQ: VVOS) has reported cost-saving measures in its 2026 fiscal year second quarter, primarily driven by staff reductions, vendor changes, and contract renegotiations. These adjustments have contributed to a reduction in operating expenses, aligning with the company’s…
AInvest Wire · Sep 29, 2026Vivos Therapeutics reports progress in material cost reductions and revenue growth initiatives
AInvest Wire · Sep 29, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.